When you visit any of the websites within the University of Cambridge domain we hold certain information about you for service and security reasons. For more information on this, please see http://www.cam.ac.uk/about-this-site/privacy-policy.
The Institute of Metabolic Science-Metabolic Research Laboratories (IMS-MRL) and its embedded Medical Research Council (MRC) Metabolic Diseases Unit investigate the mechanisms through which metabolic health is maintained and how this is disturbed in disease. We seek to use that knowledge to aid better treatment and prevention of obesity, Type 2 diabetes and related endocrine and metabolic diseases.
IMS-MRL research groups encompass skills in genetics, cell biology, cell signalling, neuroendocrinology, bioenergetics, human and animal physiology, experimental medicine and clinical trials.
Latest news
Rare gene variants reveal a new Prader-Willi-like Syndrome behind childhood obesity
2 July 2025
Researchers from the Yeo group at the IMS-MRL including Giles Yeo, Anna-Maria Siegert, and Loraine Tung , working in collaboration with Institut Pasteur de Lille, Imperial College London and research teams in Pakistan, have identified that mutations in the SREK1 gene result in severe early onset obesity and share features...
22 May 2025
Congratulations to Professor Stephen O'Rahilly from the IMS-MRL and Professor Jens Juul Holst (Copenhagen University, Denmark) who are joint winners of the Distinguished Service Award presented at the 2nd Lund Spring Symposium taking place in Sweden this week. Professor Holst co-discovered the hormone glucagon-like peptide...
Professor Frank Reimann announced as a new Academy of Medical Sciences Fellow
22 May 2025
The Academy of Medical Sciences (AMS) has announced its newly elected biomedical and health scientists to its prestigious Fellowship, and we are delighted that Professor Frank Reimann from the IMS-MRL is included in the list of 54 exceptional researchers. Frank is Professor of Endocrine Signalling and his research lab, in...
